BackAtyr Pharma Overview

Atyr Pharma Minority Interest

Atyr Pharma's minority interest is $-190K.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$-194000.00
2.65% YoYΔ $-5000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Atyr Pharma Minority Interest History

Loading

Atyr Pharma vs. peers: Minority Interest Comparison

Loading

Atyr Pharma Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Atyr Pharma (LIFE) FAQ

As of the most recent data (June 2026), LIFE shows a minority interest of $-190K. That compares with $-190K in the prior-year period — down 2.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIFE's minority interest is now $-190K (was $-190K) — a 2.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Atyr Pharma is outperforming or lagging.

Tracking LIFE's minority interest over time shows whether Atyr Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $-190K That compares with $-190K in the prior-year period — down 2.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Atyr Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $-190K) with ownership activity and broader fundamentals.

Atyr Pharma's minority interest is $-190K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.